These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid. Johnson DR; Stebulis JA; Rossetti RG; Burstein SH; Zurier RB J Cell Biochem; 2007 Jan; 100(1):184-90. PubMed ID: 16927387 [TBL] [Abstract][Full Text] [Related]
9. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. Zurier RB; Sun YP; George KL; Stebulis JA; Rossetti RG; Skulas A; Judge E; Serhan CN FASEB J; 2009 May; 23(5):1503-9. PubMed ID: 19124557 [TBL] [Abstract][Full Text] [Related]
10. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. Liu J; Li H; Burstein SH; Zurier RB; Chen JD Mol Pharmacol; 2003 May; 63(5):983-92. PubMed ID: 12695526 [TBL] [Abstract][Full Text] [Related]
11. Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells. Stebulis JA; Johnson DR; Rossetti RG; Burstein SH; Zurier RB Life Sci; 2008 Nov; 83(19-20):666-70. PubMed ID: 18840450 [TBL] [Abstract][Full Text] [Related]
12. Ajulemic acid: A novel cannabinoid produces analgesia without a "high". Burstein SH; Karst M; Schneider U; Zurier RB Life Sci; 2004 Aug; 75(12):1513-22. PubMed ID: 15240185 [TBL] [Abstract][Full Text] [Related]
13. Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity. Tepper MA; Zurier RB; Burstein SH Bioorg Med Chem; 2014 Jul; 22(13):3245-51. PubMed ID: 24856183 [TBL] [Abstract][Full Text] [Related]
14. Suppression of human monocyte interleukin-1beta production by ajulemic acid, a nonpsychoactive cannabinoid. Zurier RB; Rossetti RG; Burstein SH; Bidinger B Biochem Pharmacol; 2003 Feb; 65(4):649-55. PubMed ID: 12566094 [TBL] [Abstract][Full Text] [Related]
15. Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma. Ambrosio ALB; Dias SMG; Polikarpov I; Zurier RB; Burstein SH; Garratt RC J Biol Chem; 2007 Jun; 282(25):18625-18633. PubMed ID: 17462987 [TBL] [Abstract][Full Text] [Related]
16. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells. George KL; Saltman LH; Stein GS; Lian JB; Zurier RB J Cell Physiol; 2008 Mar; 214(3):714-20. PubMed ID: 17786950 [TBL] [Abstract][Full Text] [Related]
17. Cannabimimetic properties of ajulemic acid. Vann RE; Cook CD; Martin BR; Wiley JL J Pharmacol Exp Ther; 2007 Feb; 320(2):678-86. PubMed ID: 17105826 [TBL] [Abstract][Full Text] [Related]
18. Pain measurements and side effect profile of the novel cannabinoid ajulemic acid. Salim K; Schneider U; Burstein S; Hoy L; Karst M Neuropharmacology; 2005 Jun; 48(8):1164-71. PubMed ID: 15910892 [TBL] [Abstract][Full Text] [Related]
19. Determination of ajulemic acid and its glucuronide in human plasma by gas chromatography-mass spectrometry. Batista C; Berisha M; Karst M; Salim K; Schneider U; Brenneisen R J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):77-82. PubMed ID: 15866495 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoids, endocannabinoids, and related analogs in inflammation. Burstein SH; Zurier RB AAPS J; 2009 Mar; 11(1):109-19. PubMed ID: 19199042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]